Q3 FY26 Earnings Results
Q3 FY26 earnings, Oct–Dec 2025: 5,048 Indian listed companies have reported; median profit growth is +2.2% on last year, and 143 of 376 companies with analyst estimates beat them. Quarter ended 31 Dec 2025.
Reported
5,048
companies
Profit breadth
51% / 46%
grew / declined · 3,531 comparable
Median sales YoY
+8.3%
across all reporters
Median profit YoY
+2.2%
across all reporters
Beat / missed
143 / 210
of 376 covered
Strongest / weakest
Automobiles +23.4%
Consumer Services −36.6%
median profit growth, 10+ reporters
Clear filters 1–55 of 55
| Company | Revenue (₹ Cr) | Profit (₹ Cr) | Per share | 8Q profit | |||||
|---|---|---|---|---|---|---|---|---|---|
| Symbol | Sector | Reported | YoY | QoQ | Reported | YoY | EPS | vs consensus | Trend |
 APOLLOHOSP Apollo Hospitals Enterprise Ltd | Healthcare Services | 6,477 | up+17.2% | up+2.7% | 516 | up+36.1% | 34.93 | Beat +2.1% est. 34.21 | |
 FORTIS Fortis Healthcare Ltd | Healthcare Services | 2,265 | up+17.5% | down−2.8% | 197 | down−22.4% | 2.57 | Miss −24.8% est. 3.42 | |
 NH Narayana Hrudayalaya Ltd | Healthcare Services | 2,151 | up+61.1% | up+30.8% | 127 | down−34.2% | 6.20 | Miss −54.8% est. 13.80 | |
 MAXHEALTH Max Healthcare Institute Ltd | Healthcare Services | 2,068 | up+10.7% | down−3.1% | 301 | up+25.9% | 3.09 | Miss −21.8% est. 3.96 | |
 ASTERDM Aster DM Quality Care Ltd | Healthcare Services | 1,186 | up+13.0% | down−0.9% | 59 | down−7.8% | 1.01 | No estimate | |
 MEDANTA Global Health Ltd | Healthcare Services | 1,121 | up+18.9% | up+2.0% | 95 | down−33.6% | 3.54 | Miss −26.3% est. 4.80 | |
 KIMS Krishna Institute of Medical Sciences Ltd | Healthcare Services | 998 | up+29.3% | up+3.9% | 52 | down−43.5% | 1.33 | Beat +33.0% est. 1.00 | |
 LALPATHLAB Dr Lal Pathlabs Ltd | Healthcare Services | 660 | up+10.6% | down−9.7% | 91 | down−7.1% | 5.40 | Miss −20.4% est. 6.81 | |
 HCG Healthcare Global Enterprises Ltd | Healthcare Services | 633 | up+13.2% | down−2.2% | −8 | down−200.0% | −0.63 | Miss −192.5% est. 0.74 | |
 AGARWALEYE Dr Agarwals Health Care Ltd | Healthcare Services | 530 | up+23.0% | up+6.2% | 44 | up+57.1% | 1.07 | Beat +7.0% est. 1.00 | |
 RAINBOW Rainbow Childrens Medicare Ltd | Healthcare Services | 445 | up+11.8% | 0.0% | 74 | up+7.2% | 7.14 | In line +2.0% est. 7.00 | |
 PARKHOSPS Park Medi World Ltd | Healthcare Services | 410 | up+17.8% | 0.0% | 53 | up+15.2% | 1.17 | No estimate | |
 KOVAI Kovai Medical Center & Hospital Ltd | Healthcare Services | 407 | up+14.6% | up+3.8% | 65 | up+12.1% | 59.42 | No estimate | |
 METROPOLIS Metropolis Healthcare Ltd | Healthcare Services | 406 | up+25.7% | down−5.4% | 42 | up+35.5% | 2.00 | Beat +252.1% est. 2.27 | |
 INDRAMEDCO Indraprastha Medical Corporation Ltd | Healthcare Services | 372 | up+14.5% | down−2.4% | 41 | up+24.2% | 4.47 | No estimate | |
 JLHL Jupiter Life Line Hospitals Ltd | Healthcare Services | 365 | up+9.6% | down−7.4% | 42 | down−19.2% | 1.30 | No estimate | |
 HEALTHX Sastasundar Ventures Ltd | Healthcare Services | 346 | up+22.9% | up+14.7% | 0 | n/a | 0.36 | No estimate | |
 YATHARTH Yatharth Hospital & Trauma Care Services Ltd | Healthcare Services | 320 | up+46.1% | up+14.7% | 43 | up+43.3% | 4.71 | No estimate | |
 SHALBY Shalby Ltd | Healthcare Services | 272 | down−1.4% | down−4.6% | 1 | n/a | 0.16 | No estimate | |
 ARTEMISMED Artemis Medicare Services Ltd | Healthcare Services | 267 | up+17.6% | down−1.1% | 23 | up+9.5% | 1.42 | No estimate | |
 NEPHROPLUS Nephrocare Health Services Ltd | Healthcare Services | 260 | up+32.0% | up+5.7% | 32 | up+60.0% | 3.21 | No estimate | |
 VIJAYA Vijaya Diagnostic Centre Ltd | Healthcare Services | 205 | up+21.3% | up+1.5% | 43 | up+22.9% | 4.20 | Beat +7.7% est. 3.90 | |
 THYROCARE Thyrocare Technologies Ltd | Healthcare Services | 196 | up+18.1% | down−9.7% | 28 | up+47.4% | 1.82 | No estimate | |
 KRSNAA Krsnaa Diagnostics Ltd | Healthcare Services | 159 | down−3.6% | down−13.1% | 16 | down−27.3% | 5.08 | Miss −17.2% est. 5.70 | |
 ONEGLOBAL One Global Service Provider Ltd | Healthcare Services | 141 | up+327.3% | up+4.4% | 22 | up+633.3% | 11.08 | No estimate | |
 GPTHEALTH GPT Healthcare Ltd | Healthcare Services | 120 | up+17.6% | up+0.8% | 9 | down−25.0% | 1.14 | No estimate | |
 DRAGARWQ Dr Agarwals Eye Hospital Ltd | Healthcare Services | 116 | up+22.1% | down−1.7% | 17 | up+70.0% | 35.76 | No estimate | |
 KMCSHIL KMC Speciality Hospitals (India) Ltd | Healthcare Services | 82 | up+34.4% | up+9.3% | 14 | up+75.0% | 0.84 | No estimate | |
 SURAKSHA Suraksha Diagnostic Ltd | Healthcare Services | 78 | up+30.0% | down−1.3% | 7 | up+16.7% | 1.44 | No estimate | |
 CHANDAN Chandan Healthcare Ltd | Healthcare Services | 65 | up+19.0% | down−4.3% | 5 | up+8.1% | 1.86 | No estimate | |
 3BBLACKBIO 3B Blackbio DX Ltd | Healthcare Services | 50 | up+98.3% | up+48.5% | 22 | up+66.3% | 25.32 | No estimate | |
 ASARFIHOSPITALLTD | Healthcare Services | 46 | up+40.0% | up+2.7% | 5 | up+101.5% | 2.78 | No estimate | |
 TRIJALINDUSTRIESLTD Abate As Industries Ltd | Healthcare Services | 43 | n/a | up+1.3% | 3 | n/a | 0.19 | No estimate | |
 GKSL Gujarat Kidney & Super Speciality Ltd | Healthcare Services | 23 | up+97.2% | up+79.8% | 4 | up+46.2% | 0.37 | No estimate | |
 NEPHROCARE Nephro Care India Ltd | Healthcare Services | 23 | n/a | n/a | 0 | n/a | 0.25 | No estimate | |
 DECCANHEALTHCARELTD | Healthcare Services | 17 | down−14.9% | down−18.7% | 1 | up+614.3% | 0.40 | No estimate | |
 BANDARAMPHARMAPACKTECHLTD | Healthcare Services | 15 | up+48.4% | up+8.2% | 0 | n/a | 0.11 | No estimate | |
 LOTUSEYE Lotus Eye Hospital & Institute Ltd | Healthcare Services | 14 | up+10.6% | up+3.9% | 0 | n/a | −0.13 | No estimate | |
 CHOKSILABORATORIESLTD | Healthcare Services | 11 | up+4.2% | down−2.7% | 0 | up+181.8% | 0.45 | No estimate | |
 SHARMAEASTINDIAHOSPITALLTD Sharma East India Hosp and Medical Research Ltd | Healthcare Services | 10 | up+17.9% | up+2.5% | 0 | down−37.9% | — | No estimate | |
 CHENNAIMEENAKSHIMULTISPECIALLTD Chennai Meenakshi Multispeciality Hospital Ltd | Healthcare Services | 9 | up+3.2% | down−3.8% | −1 | n/a | −0.72 | No estimate | |
 DHANVANTRIJEEVANREKHALTD | Healthcare Services | 7 | up+27.5% | up+24.5% | 0 | up+13.3% | 0.41 | No estimate | |
 SONIMEDICARELTD | Healthcare Services | 6 | down−27.5% | down−13.2% | −1 | n/a | −2.65 | No estimate | |
 ASPIRAPATHLABLTD Aspira Pathlab & Diagnostics Ltd | Healthcare Services | 5 | down−5.4% | down−36.7% | −2 | down−510.5% | −1.52 | No estimate | |
 NGINDUSTRIESLTD | Healthcare Services | 4 | up+7.3% | up+5.9% | 0 | down−93.7% | 1.25 | No estimate | |
 TEJNAKSHHEALTHCARELTD | Healthcare Services | 3 | down−17.9% | down−12.1% | 0 | down−50.0% | 0.15 | No estimate | |
 GIANLIFECARELTD | Healthcare Services | 1 | down−29.6% | up+69.7% | 0 | down−71.4% | 0.10 | No estimate | |
| Dolphin Medical Services Ltd | Healthcare Services | 0 | down−12.5% | up+16.7% | 0 | up+100.0% | 0.01 | No estimate | |
 ASHRAMONLINECOMLTD Ashram Online.com Ltd | Healthcare Services | 0 | 0.0% | 0.0% | 0 | n/a | −0.04 | No estimate | |
 LOOKSHEALTHSERVICESLTD | Healthcare Services | 0 | n/a | up+71.4% | 0 | n/a | 0.01 | No estimate | |
 SCANDENTIMAGINGLTD Family Care Hospitals Ltd | Healthcare Services | 0 | up+100.0% | down−14.3% | −1 | n/a | −0.18 | No estimate | |
| BOSTONBIOSYSTEMSLTD Boston Commerce Limited | Healthcare Services | 0 | n/a | down−75.0% | 0 | n/a | −0.01 | No estimate | |
 TRANSGENEBIOTEKLTD | Healthcare Services | 0 | down−37.5% | 0.0% | 0 | n/a | −0.05 | No estimate | |
 FORTISMALARHOSPITALSLTD | Healthcare Services | 0 | n/a | down−100.0% | 0 | up+100.0% | 0.01 | No estimate | |
 DRHABEEBULLAHLIFELTD Samsrita Labs Ltd | Healthcare Services | 0 | n/a | n/a | −3 | n/a | −1.29 | No estimate | |
About Q3 FY26 earnings data
When are Q3 FY26 results announced?
Q3 FY26 covers the Oct–Dec 2025 quarter. Indian listed companies have up to 45 days after a quarter closes to file their results — 60 days for the January–March quarter — so results arrive in a wave over the weeks that follow rather than all at once. A quarter that has only just ended will look sparse and fill in.
Why do some Q3 FY26 growth figures show "n/a" instead of a percentage?
Growth is left blank whenever the comparison period was not profitable. A percentage change measured from a loss is arithmetic without meaning — a swing from a ₹10 crore loss to a ₹10 crore profit is not "200% growth", and publishing it as such would flatter the company. The reported figures for both periods are still shown, so the change is there to read directly.
Does the beat/miss verdict cover every company?
No, and the denominator matters. An analyst consensus existed for 376 of the 5,048 companies that reported Q3 FY26 — 7.4%. Beat, missed and in-line describe only those. Every other company is marked "no estimate" rather than being counted as in line, because nobody forecast it. Revenue and profit growth, by contrast, cover every company in the table.
What counts as an in-line result rather than a beat or a miss?
Reported earnings per share within ±2% of the consensus estimate. The band is set there because a tighter one classifies rounding as news, and a wider one swallows surprises that genuinely moved a stock.
Are the figures consolidated or standalone?
Consolidated where a company reports on that basis, standalone otherwise, with all money in ₹ crore. Figures are as filed by the company with the exchanges (NSE/BSE); they are not restated or adjusted.
What does the 8-quarter trend line show?
Quarterly net profit for the last eight quarters, oldest on the left, always ending on the quarter shown in the row. Two years covers both the seasonal shape of the business and its direction. The line breaks where a quarter is missing rather than drawing across the gap, so a break is a real absence of data and not a reported collapse.
How do I find only the companies that beat estimates in Q3 FY26?
Use the Result filter above the table and choose Beat, or sort by EPS surprise to rank every covered company by how far it landed from consensus. Both are reflected in the page URL, so a filtered view can be bookmarked or shared.
Figures are as reported by companies in their quarterly filings to the exchanges (NSE/BSE), in ₹ crore. Consolidated results are shown where a company reports them, otherwise standalone. Year-on-year and quarter-on-quarter growth is omitted where the comparison period was loss-making, since a percentage change from a negative base is not meaningful. Analyst consensus is an estimate, not a forecast of outcome.